Doctivo Lifesciences is a finished-dose manufacturer based in India. It appears in 46 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO) and ARCSA (EC). Its GMP standing is certified by CDSCO (India). Customs aggregates show $1.1M of exports covering 65 molecules to 5 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Kangra, India | 3032514730 |
| amraiwadi roadahmedabad 380 008ahmedabad, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 25 | None |
| ARCSA (EC) | 21 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $276K | 2 |
| 2025 | Not reported | $1.1M | 5 |
| 2024 | Not reported | $941K | 5 |
| 2023 | Not reported | $818K | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Doctivo Lifesciences comes back tiered against every other supplier able to file there.
Start for free